The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Pabrinex Intravenous High Potency Concentrate for Solution for Infusion

. Concentrate for solution for infusion

Kyowa Kirin Holdings B.V.PA2288/001/001

Main Information

Trade NamePabrinex Intravenous High Potency Concentrate for Solution for Infusion
Active SubstancesGlucose (as monohydrate)
Thiamine hydrochloride
Nicotinamide
Pyridoxine hydrochloride
Riboflavine
Ascorbic acid
Strength.
Dosage FormConcentrate for solution for infusion
Licence HolderKyowa Kirin Holdings B.V.
Licence NumberPA2288/001/001

Group Information

ATC CodeA11EB Vitamin B-complex with vitamin C

Status

Authorised/WithdrawnAuthorised
Licence Issued20/08/1987
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back